SWOG clinical trial number
SWOG-8912
Evaluation of Fazarabine in Patients with Recurrent Squamous Cell Carcinoma of the Head and Neck
Closed
Phase
Accrual
60%
Published
Abbreviated Title
Evaluation of Fazarabine in Patients with Recurrent Squamous Cell Carcinoma of the Head and Neck
Activated
07/15/1989
Closed
01/01/1991
Publication Information Expand/Collapse
1991
Phase II study of fazarabine in advanced head and neck cancer. A Southwest Oncology Group study.